Drug stocks slide; Elan climbs on J&J deal

Drug stocks slid into the red early Thursday while shares of Elan Corp. rallied on news that Johnson & Johnson was making a $1 billion investment in the company.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.